Delivery Order SPE2DB24D2101-SPE2DB25FKPHW
Award Date 9/9/25
Potential Completion Date 9/30/25
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,327.94 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela (1,600 mg-26,800 13.4ml) on September 10, 2025, with completion expected by October 1, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $29,744.16 firm fixed price delivery order on July 28, 2025, for the supply of Rituxan Hycela (1,400 mg-23,400 11.7 mL), a monoclonal antibody immunosuppressant used in treating rheumatoid arthritis and certain lymphomas. This non-set-aside competitive award will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $37,180.20 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rituxan Hycela (1,400 mg-23,400 11.7 mL), a biologic medication used in oncology and immunology treatment. This firm fixed-price delivery order, which represents no set-aside opportunity, is scheduled for completion by September 8, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania location. The award is classified as a child...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,718.02, is for the supply of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela. The contract is a firm fixed price agreement and has an ultimate completion date of February 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $29,254.08 firm fixed price contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug RITUXAN HYCELA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,718.02, is for the delivery of Rituxan Hycela 1,400 mg-23,400 11.7 ml. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 21, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 1,600 mg-26,800 13.4 ml RITUXAN HYCELA pharmaceuticals. The contract has a completion date of March 12, 2024 and a potential value of $4,167.13. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $7,313.52, is for the delivery of the drug Rituxan Hycela 1,400 mg-23,400 11.7 ml. It is a firm fixed-price delivery order with a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RITUXAN HYCELA, a medication used to treat certain types of cancer and autoimmune disorders, with a ceiling value of $22,531.18. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 5, 2025. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded a $14,818 delivery order to Amerisourcebergen Drug Corporation for RITUXAN HYCELA, a monoclonal antibody used to treat certain types of cancer and autoimmune disorders. The firm fixed price order is for delivery of 1,400 mg doses to a facility in Conshohocken, Pennsylvania between June and July 2023. Amerisourcebergen will fulfill the order as the prime contractor from its Corporate Office Division. No additional details were provided regarding subcontractors...